The Journal of Bone and Joint Surgery (American). 2006;88:1223-1230.
doi:10.2106/JBJS.E.00706
© 2006 The Journal of Bone and Joint Surgery, Inc.
Analysis of Transfusion Predictors in Shoulder Arthroplasty
Peter J. Millett, MD, MSc1,
Mason Porramatikul, MD2,
Neal Chen, MD3,
David Zurakowski, PhD4 and
Jon J.P. Warner, MD5
1 Steadman Hawkins Clinic, 181 West Meadow Drive, Vail, CO 81657. E-mail
address:
drmillett{at}steadman-hawkins.com
2 Department of Orthopedic Surgery, Bangkok Metropolitan Administration, Medical
College and Vajira Hospital, 681 Samsen Road, Dusit District, Bangkok 10300,
Thailand
3 Harvard Combined Orthopaedic Residency Program, 55 Fruit Street, Boston, MA
02114
4 Department of Orthopaedic Surgery, Children's Hospital Boston, 300 Longwood
Avenue, Boston, MA 02115
5 Harvard Shoulder Service, 55 Fruit Street, Yawkey Center for Outpatient Care,
Suite 3200, 3G, Room 3-044, Boston, MA 02114
Investigation performed at Harvard Shoulder Service, Brigham and
Women's Hospital, and Massachusetts General Hospital, Boston,
Massachusetts
The authors did not receive grants or outside funding in support of their
research for or preparation of this manuscript. They did not receive payments
or other benefits or a commitment or agreement to provide such benefits from a
commercial entity. No commercial entity paid or directed, or agreed to pay or
direct, any benefits to any research fund, foundation, educational
institution, or other charitable or nonprofit organization with which the
authors are affiliated or associated.
Background: We are not aware of any previous study that has examined
predictive factors for blood transfusion after shoulder arthroplasty. We
analyzed the association between clinical factors and the need for
postoperative blood transfusion and documented the use and waste of predonated
blood in a group of patients managed with shoulder arthroplasty.
Methods: A retrospective study of 119 patients who underwent 124
shoulder arthroplasties (including eighty-seven primary uncomplicated total
shoulder arthroplasties, twenty-seven revision or complicated primary total
shoulder arthroplasties, and ten hemiarthroplasties) from 2001 to 2004 was
performed. Logistic regression analysis was conducted to determine which
clinical variables were predictive of transfusion.
Results: A postoperative transfusion was received after thirty-one
arthroplasties (25%). The strongest predictor of blood transfusion after
shoulder arthroplasty was the preoperative hemoglobin level (likelihood ratio
test = 37.8, p < 0.0001). Patients with a preoperative hemoglobin level of
between 110 and 130 g/L had a five times greater estimated risk of transfusion
than those with a level of >130 g/L (p < 0.001). Gender, body mass
index, preoperative diagnosis, comorbid conditions, use of anticoagulants or
aspirin, autologous predonation status, type of anesthesia, operative time,
and decrease in hemoglobin or hematocrit were not predictors of blood
transfusion. One hundred and two (78%) of the 131 predonated autologous units
were discarded. Patients with a preoperative hemoglobin level of >130 g/L
had the highest percentage of wasted units (90%; fifty-five of sixty-one).
Preoperative autologous blood donation did not eliminate the risk of
allogeneic blood transfusion in autologous donors.
Conclusions: The preoperative hemoglobin level is the strongest
predictor of blood transfusion after shoulder surgery, and individuals with a
preoperative hemoglobin level of <110 g/L have the highest risk of
transfusion. On the basis of these findings, we do not recommend autologous
predonation for individuals with a preoperative hemoglobin level of >130
g/L, to avoid unnecessary expense and waste.
Level of Evidence: Prognostic Level II. See Instructions
to Authors for a complete description of levels of evidence.

CiteULike Connotea Del.icio.us Technorati What's this?
|